Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.

Authors :: van Zeijl, Michiel C.T.
van Breeschoten, Jesper
de Wreede, Liesbeth C.
Wouters, Michel W.J.M.
Hilarius, Doranne L.
Blank, Christian U.
Aarts, Maureen J.B.
van den Berkmortel, Franchette W.P.J.
de Groot, Jan Willem B.
Hospers, Geke A.P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Rozemarijn S.
Stevense-den Boer, Marion A.
van der Veldt, Astrid A.M.
Vreugdenhil, Gerard
Boers-Sonderen, Marye J.
Suijkerbuijk, Karijn P.M.
Haanen, John B.A.G.
van den Eertwegh, Alfons J.M.
Source :: Journal of Immunotherapy; Jun2023, Vol. 46 Issue 5, p197-204, 8p
Publication Year :: 2023

Full Text Access

Tools